These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23372345)

  • 1. LGR5 is a promising biomarker for patients with stage I and II gastric cancer.
    Bu Z; Zheng Z; Zhang L; Li Z; Sun Y; Dong B; Wu A; Wu X; Wang X; Cheng X; Xing X; Li Y; Du H; Ji J
    Chin J Cancer Res; 2013 Feb; 25(1):79-89. PubMed ID: 23372345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Leucine-rich Repeat-containing G-protein Coupled Receptor 5 and CD44: Potential Implications for Gastric Cancer Stem Cell Marker.
    Choi YJ; Kim N; Lee HS; Park SM; Park JH; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
    J Cancer Prev; 2016 Dec; 21(4):279-287. PubMed ID: 28053963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma.
    Kuraishi Y; Uehara T; Kobayashi Y; Nakajima T; Watanabe T; Shimizu A; Ota H; Tanaka E
    Pathol Res Pract; 2019 Nov; 215(11):152623. PubMed ID: 31543221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance.
    Yu L; Mao X; Wu S; Zhou L; Song W; Gong X; Wang D
    Int J Clin Exp Pathol; 2019; 12(1):327-336. PubMed ID: 31933749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer.
    Xi HQ; Cui JX; Shen WS; Wu XS; Bian SB; Li JY; Song Z; Wei B; Chen L
    Oncol Rep; 2014 Jul; 32(1):181-8. PubMed ID: 24859092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma.
    Ehara T; Uehara T; Nakajima T; Kinugawa Y; Kobayashi S; Iwaya M; Ota H; Soejima Y
    BMC Cancer; 2021 Mar; 21(1):228. PubMed ID: 33676447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
    Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 16. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 predicts poor prognosis in hepatocellular carcinoma.
    Chen W; Fu Q; Fang F; Fang J; Zhang Q; Hong Y
    Saudi J Biol Sci; 2018 Jul; 25(5):904-908. PubMed ID: 30108439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications and Prognostic Value of Leucine-Rich G Protein-Coupled Receptor 5 Expression as A Cancer Stem Cell Marker in Malignancies: A Systematic Review and Meta-Analysis.
    Ghobakhloo S; Khoshhali M; Vatandoost N; Jafarpour S; Niazmand A; Nedaeinia R; Salehi R
    Cell J; 2024 Jan; 26(1):1-12. PubMed ID: 38351725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
    Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
    PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice.
    Li XB; Yang G; Zhu L; Tang YL; Zhang C; Ju Z; Yang X; Teng Y
    Cell Res; 2016 Jul; 26(7):838-49. PubMed ID: 27091432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.